FDA 483 - Pascal Company Inc - August 21, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Pascal Company Inc in Bellevue, WA, revealed significant deficiencies in manufacturing controls, laboratory practices, and data integrity. The firm failed to adequately validate manufacturing processes for topical fluoride gels, lacked proper specifications and investigations for out-of-specification results, and exhibited poor controls over computer systems used for testing. These observations indicate a lack of assurance regarding the identity, strength, purity, and quality of their drug products.
ID · c122ac61-cc0a-4cf9-8aec-9accb5ff891b